SCHEMBL16417787

SCHEMBL16417787

CCOC(=O)CCC[N+](C)(C)CCF

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BBOX1 O75936 6/20 0.59
▸ CYP1A2 P05177 1/20 0.53
▸ NR1I2 O75469 1/20 0.40
▸ PGR P06401 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ PTGS2 P35354 1/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ MGAM O43451 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ SI P14410 1/20 0.39
▸ MGAM2 Q2M2H8 1/20 0.39
▸ ADRA2A P08913 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL13731124 0.98 BBOX1 (0.61) BBOX1CYP1A2NR1I2PGRADORA3
SCHEMBL15625159 0.83 BBOX1 (0.57) BBOX1CYP1A2NR1I2PGRADORA3
SCHEMBL8444876 0.82 CYP1A2 (0.48) BBOX1CYP1A2NR1I2PGRADORA3
Bromide SCHEMBL1671983 0.81 BBOX1 (0.55) BBOX1CYP1A2NR1I2PGRADORA3
Bromide SCHEMBL4618327 0.81 BBOX1 (0.47) BBOX1CYP1A2NR1I2PGRADORA3
Bromide SCHEMBL4620693 0.79 BBOX1 (0.46) BBOX1CYP1A2NR1I2PGRADORA3
SCHEMBL13396799 0.79 CYP1A2 (0.57) CYP1A2NR1I2PGRADORA3PTGS2
SCHEMBL2126051 0.78 — —
Bromide SCHEMBL11326341 0.77 DGKA (0.56) CYP1A2ALDH1A1TSHRMAPTDGKA
Bromide SCHEMBL11571925 0.77 DGKA (0.56) CYP1A2ALDH1A1TSHRMAPTDGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8940793-B2 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease JSC GRINDEKS (LV) 2015-01-27 — — US disclosed
US-8940793-B2 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease JSC GRINDEKS (LV) 2015-01-27 — — US disclosed
US-20140107202-A1 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease JSC GRINDEKS (LV) 2014-04-17 — — US disclosed
US-20140107202-A1 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease JSC GRINDEKS (LV) 2014-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140107202-A1 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease FABP3, HCN3, HCN4 BBOX1 38/4885CYP1A2 930/4885NR1I2 1494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback